COVID-19 in North Africa: An Epidemiological Analysis of Cases, Deaths, and Vaccination Efforts (2020-2023)

Document Type : Original Research

Authors
1 Laboratory of Microbiology applied to the Food industry, Biomedical and the Environment, Faculty of Natural and Life Sciences, Earth and Universe Sciences. Department of Biology. University of Tlemcen, Algeria
2 Biomedical Engineering Laboratory, Faculty of Technology, University of Tlemcen, Algeria
Abstract
Aims: SARS-CoV-2, the virus responsible for the COVID-19 pandemic, has caused a worldwide health crisis, impacting millions of individuals across the globe. The focus of In this study, is to conduct an epidemiological investigation was carried out on the progression of COVID-19 in the North African region, encompassing Morocco, Algeria, Tunisia, Libya, and Egypt, from January 2020 to May 2023. The aim of this study was to conduct an epidemiological investigation into the progression of COVID-19 in the North African region, encompassing Morocco, Algeria, Tunisia, Libya, and Egypt, from January 2020 to May 2023, with a primary focus on analyzing and understanding the COVID-19 data in these five North African countries.

Materials & Methods: This research aimed toinvolved the observeation and analyzesis of an international database from our World in Data, using SPSS and Excel,. A comparative analysis was carried out, considering the number of COVID-19 cases, fatalities, and vaccination rates in the five specified North African countries.

Findings: Over the course of three years, a total of 3,722,56017,862 new COVID-19 cases and 83,860757 deaths were documented in North African countries, and the year 2021 emerged as the most devastating period, with the highest number of COVID-19 cases (1,767,410) and fatalities (50,341) across the region. Among the countries studied, Morocco (1,274,180 cases, 34.23% ) and Tunisia (1,153,261 cases, 31%) of cases, reportedwere the mosthighest infection ratesaffected, with Morocco reporting 1,272,490 cases (34%) and Tunisia 150,962 cases (31%). Similarly, the highest death tolls were recorded in Tunisia , accounting for (29,415331 deaths, (35%), and Egypt, with (24,83012 deaths, (30%). Additionally, Morocco led the region in vaccination efforts in the region, administering 47% of the total of 384,851,069 vaccine doses.

Conclusion: The COVID-19 pandemic has posed a significant global health challenge, affecting each North African country differently, depending on various factors such as their population, control measures, and vaccination campaigns. This study emphasizes the importance of continued efforts and tailored strategies for each country in the region to combat the pandemic in the region and underscores the significance of tailored strategies for each country to effectively address the ongoing crisis.

Keywords


1. Zatla I, Boublenza L, Hassaine H. The first days and months of the COVID-19 pandemic. Res Rev J Microbiol Virol. 2022;12(1):7–13.
2. Prime H, Wade M, Browne DT. Risk and resilience in family well-being during the COVID-19 pandemic. Am Psychol. 2020;75(5):631-43.
3. Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, et al. Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu province: A multicenter descriptive study. Clin Infect Dis. 2020;71(15):706-12.
4. Tohic S, Basso S, Peillard L. Risk mapping associated with organization of a COVID-19 immunization campaign. Ann Pharm Fr. 2022;80(5):697-710.
5. Zatla I, Boublenza L. The COVID-19 outbreak inception in Algeria: What happened? Alger J Health Sci. 2023;5(1):35-8.
6. Bounouh A. The devastating impact of covid-19 on the health system in Tunisia. Mor J Public Heath. 2021;2(1):22-44.
7. Belamghari M. Distance learning amidst the COVID-19 pandemic: Moroccan university students’ perceptions. Teach Educ. 2022;57(1):79-95.
8. Samouh Y, Sefrioui MR, Derfoufi S, Benmoussa A. COVID-19 vaccine acceptance among Moroccan students: A cross-sectional study. Pan Afr Med J. 2021;38(1):381.
9. Matusik É, Ayadi M, Picard N. COVID-19, management, therapeutic and vaccine approaches. Actual Pharm. 2020;59(599):27-33.
10. Ninich O, Ettahir A, Jossou TR, Kamal K, Medenou D. Impact of the strategies deployed by Morocco to reduce health and socio-economic risks during the first half of the COVID-19 pandemic. Glob Econ Sci. 2021;2(1):45–60.
11. Khalis M, Hatim A, Elmouden L, Diakite M, Marfak A, Ait El Haj S, et al. Acceptability of COVID-19 vaccination among health care workers: A cross-sectional survey in Morocco. Hum Vaccin Immunother. 2021;17(12):5076-81.
12. Dzinamarira T, Dzobo M, Chitungo I. COVID-19: A perspective on Africa's capacity and response. J Med Virol. 2020;92(11):2465-72.
13. Zatla I, Boublenza L, Zair S, Diab N. Vaccination in the time of COVID-19: Survey study at the University of Tlemcen in the spring of 2022. J Epidemiology Public Health. 2023;8(4):434–40.
14. Hamimes A, Aouissi HA, Ababsa M, Lounis M, Jayarajah U, Napoli C, et al. The effect of preventive measures and vaccination against SARS-CoV-2 on the infection risk, treatment, and hospitalization: A cross-sectional study of Algeria. Viruses. 2022;14(12):2771.